Condition: Corneal Transplantation · Sponsor: Claus Cursiefen
The trial evaluates the effect of corneal crosslinking as pre-treatment before corneal transplantation. The goal is to improve graft survival by reducing pathological vessels through pre-treatment.
This description comes directly from the study's public registry record.
Claus Cursiefen, Prof. Dr. · 00492214784300 · marie.seifert@uk-koeln.de
Deniz Hos, Dr. · 004922147898896 · deniz.hos@uk-koeln.de
Always discuss trial participation with your own doctor first.
| Augenklinik des Klinikums der Universität München | München, Bavaria, Germany | Recruiting |
| University Hospital of Cologne, Centre for Ophthalmology | Cologne, North Rhine-Westphalia, Germany | Recruiting |
| Universitätsklinikum Düsseldorf, Klinik für Augenheilkunde | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
| Universitätsklinikum des Saarlandes, Klinik für Augenheilkunde | Homburg, Saarland, Germany | Recruiting |
| Charité - Universitätsmedizin Berlin, Klinik für Augenheilkunde | Berlin, Germany | Recruiting |
| Universitätsklinikum Freiburg, Klinik für Augenheilkunde | Freiburg im Breisgau, Germany | Recruiting |
| Klinik und Poliklinik für Augenheilkunde - Universitätsmedizin Rostock | Rostock, Germany | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05870566